** GenMark Diagnostics Inc GNMK.O shares surge 29.0% to
$12.55 after co raises more equity than planned
** Diagnostic test maker sells ~7.3 mln shares, raises $70
mln urn:newsml:reuters.com:*:nGNX2xxxZH
** Deal size increased from $60 mln and prices just 6 cents
below stock's Weds close of $9.71
** Co intends to use net proceeds for general corp purposes,
including R&D, manufacturing expansion, and may also repay debt
under loan with Solar Capital Partners
** Offering represents ~12% of co's total shares outstanding
** Cowen and William Blair jt bookrunners for offering
** GNMK has tripled since end-Mar as demand for co's
COVID-19 detection test boosted Q1 placements and revenue
urn:newsml:reuters.com:*:nL4N2BW2R1
** Co received FDA Emergency Use Authorization for its ePlex
SARS-CoV-2 Test for coronavirus in Mar
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 646-223-5017))